Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine.

2.50
Hdl Handle:
http://hdl.handle.net/11287/618284
Title:
Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine.
Authors:
Jones, Angus G.; Shields, Beverley; Hyde, C. J.; Henley, W. E.; Hattersley, Andrew T.
Abstract:
Defining responders to glucose lowering therapy can be important for both clinical care and for the development of a stratified approach to diabetes management. Response is commonly defined by either HbA1c change after treatment or whether a target HbA1c is achieved. We aimed to determine the extent to which the individuals identified as responders and non-responders to glucose lowering therapy, and their characteristics, depend on the response definition chosen.
Citation:
Identifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine. 2014, 9 (10):e111235 PLoS ONE
Publisher:
PLoS
Journal:
PloS One
Issue Date:
2014
URI:
http://hdl.handle.net/11287/618284
DOI:
10.1371/journal.pone.0111235
PubMed ID:
25340784
Additional Links:
http://dx.plos.org/10.1371/journal.pone.0111235
Note:
This article is freely available online via Open Access. Click on the 'Additional Link' above to access the full text.
Type:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Language:
en
ISSN:
1932-6203
Appears in Collections:
2014 RD&E publications; Diabetes/Endocrine Services; Honorary contracts publications

Full metadata record

DC FieldValue Language
dc.contributor.authorJones, Angus G.en
dc.contributor.authorShields, Beverleyen
dc.contributor.authorHyde, C. J.en
dc.contributor.authorHenley, W. E.en
dc.contributor.authorHattersley, Andrew T.en
dc.date.accessioned2016-08-12T09:33:37Z-
dc.date.available2016-08-12T09:33:37Z-
dc.date.issued2014-
dc.identifier.citationIdentifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine. 2014, 9 (10):e111235 PLoS ONEen
dc.identifier.issn1932-6203-
dc.identifier.pmid25340784-
dc.identifier.doi10.1371/journal.pone.0111235-
dc.identifier.urihttp://hdl.handle.net/11287/618284-
dc.description.abstractDefining responders to glucose lowering therapy can be important for both clinical care and for the development of a stratified approach to diabetes management. Response is commonly defined by either HbA1c change after treatment or whether a target HbA1c is achieved. We aimed to determine the extent to which the individuals identified as responders and non-responders to glucose lowering therapy, and their characteristics, depend on the response definition chosen.en
dc.language.isoenen
dc.publisherPLoSen
dc.relation.urlhttp://dx.plos.org/10.1371/journal.pone.0111235en
dc.rightsArchived with thanks to PloS oneen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.titleIdentifying good responders to glucose lowering therapy in type 2 diabetes: implications for stratified medicine.en
dc.typeJournal Articleen
dc.typeObservational Studyen
dc.typeResearch Support, Non-U.S. Gov'ten
dc.identifier.journalPloS Oneen
dc.description.noteThis article is freely available online via Open Access. Click on the 'Additional Link' above to access the full text.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.